Dabigatran etexilate Not Yet Recruiting Phase 1 Trials for Mild Cognitive Impairment (MCI) / Mild Alzheimer's Disease Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03752294A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.